Characterizing malaria parasite drug response using single-cell transcriptomics
mBio · 16.11.2026
DOI: 10.1128/mbio.02513-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, online erschienen am 16.11.2026. Verfasst von Karla P Godinez-Macias und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of California, San Diego, La Jolla, California, USA. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill and Melinda Gates Foundation, National Institutes of Health.
Abstract (Originalsprache)
Gene expression analysis in malaria parasites has been used to define transcriptional regulatory networks but has been used less frequently to characterize parasite response to drug treatment or to show how parasites may evade killing. Here, we applied single-cell RNA sequencing (scRNA-seq) to hundreds of thousands of individually infected asynchronous red blood cells to evaluate the parasite’s response to treatment with three chemotypes that can be used for treatment (artemisinin) or prophylaxis and treatment (atovaquone and ganaplacide). We found that each treatment gave rise to different cell populations with different transcriptional profiles. Comparing single-cell transcription patterns in compound-treated cells to transcript patterns observed previously with synchronized cells showed an enrichment of cells expressing gametocyte-associated genes after artemisinin treatment but fewer life cycle perturbations after treatment with the two other compounds. In contrast, bulk analysis showed an enrichment of pyrimidine biosynthesis transcripts for atovaquone treatment. Our results show that scRNA-seq may be used to profile diverse drug responses across many life cycle stages and to potentially classify drug classes. IMPORTANCE Determining the mechanism of action (MOA) of compounds with antimalarial activity remains a key activity in both drug development and drug resistance studies but remains challenging for some chemotypes. Here we highlight the potential of single-cell transcriptional sequencing to augment the process of MOA deconvolution. We develop a new analytical pipeline that involves comparing single-cell transcription patterns to existing profiles from synchronized parasites to comprehensively characterize life cycle stage enrichments that may be observed after chemical perturbations. We also show that transcriptional feedback regulation may be present for some drug classes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, University of California, San Diego, La Jolla, California, USA.
- Institute for Genomic Medicine, University of California, San Diego, La Jolla, California, USA.
- Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, USA.
ORCID-Profile: Karla P Godinez-Macias, Jaeson Calla, Elizabeth A Winzeler
Förderung
- Bill and Melinda Gates Foundation
- National Institutes of Health
Zitieren
APA
Godinez-Macias, K. P., Calla, J., Jepsen, K., & Winzeler, E. A. (2026). Characterizing malaria parasite drug response using single-cell transcriptomics. mBio. https://doi.org/10.1128/mbio.02513-26
Vancouver
Godinez-Macias KP, Calla J, Jepsen K, Winzeler EA. Characterizing malaria parasite drug response using single-cell transcriptomics. mBio. 2026. doi:10.1128/mbio.02513-26
BibTeX
@article{GodinezMacias2026,
author = {Godinez-Macias, Karla P and Calla, Jaeson and Jepsen, Kristen and Winzeler, Elizabeth A},
title = {Characterizing malaria parasite drug response using single-cell transcriptomics},
journal = {mBio},
year = {2026},
doi = {10.1128/mbio.02513-26}
}
EUVIMED